Sammaan Capital Limited – Investor Presentation Summary

Key Operational Highlights

  • ₹3,875 crore ($407 million) disbursed in Q1FY27 across five products to approximately 12,000 new customers
  • 97% of Q1FY27 disbursements are secured loans
  • Growth diversified across multiple products maintaining healthy mix of retail/wholesale and secured/unsecured
  • ₹840 crore ($88.1 million) of Commercial Real Estate loans disbursed in partnership with one of Asia's leading Alternate Credit Funds
  • Company will pursue both Organic and Inorganic Growth opportunities

Key drivers of operational performance: Growth-oriented disbursals executed within defined risk guardrails, partnership with credit funds for CRE loans, diversified product approach

Financial Highlights

Revenue from operations: ₹1,651.93 crore

  • Interest Income: ₹1,078.17 crore
  • Fees and commission Income: ₹58.77 crore
  • Net gain on fair value changes: ₹490.98 crore
  • Net gain on derecognition of financial instruments under amortized cost category: ₹24.01 crore

Total Income: ₹1,682.81 crore

Other Income: ₹30.88 crore

Finance costs: ₹1,335.26 crore

Impairment on financial instruments (net of recoveries/written back): -₹240.47 crore

Employee benefits expenses: ₹176.61 crore

Depreciation and amortization: ₹20.11 crore

Other expenses: ₹65.29 crore

Profit before tax and exceptional items: ₹326.01 crore

Tax expense: ₹82.71 crore

  • Current tax expense: ₹4.18 crore
  • Deferred tax charge: ₹78.53 crore

Profit for the period: ₹243.30 crore

YoY/QoQ comparison: Q1FY27 profit of ₹243.30 crore compared to Q1FY26 profit of ₹334.30 crore and Q4FY26 loss of -₹8,101.41 crore

Drivers of financial performance: Net gain on fair value changes of ₹490.98 crore, impairment recovery of ₹240.47 crore, controlled finance costs

Balance Sheet Snapshot

Not Specified

Capex & Cash Flow Health

Not Specified

Strategic & R&D Initiatives

  • 53 AI use cases identified for FY27-28 across 16 departments/agile trains
  • 35 AI use cases will go live within FY27 (66% of total cases)
  • Tech initiatives include Salesforce, AWS Partnership, Darwin Box, Temenos
  • AI roadmap includes automated reconciliations, portfolio monitoring, chatbot/co-pilot for customer service & DSA
  • LSP middleware & compliance automation (Zigram)
  • Future plans include AI-driven cross-sell/next-best-offer, AI-assisted loan life-cycle, corporate loan suite fully digitized

Expected impact on growth: Productivity gains across IT, Risk, Credit & Operations, autonomous/low-touch credit decisioning at scale

Strategic Rationale: Digital-first approach with app for all individual & MSME loan products, end-to-end online loan fulfillment

Management Commentary & Growth Outlook

Disbursals Targets:

  • H1FY27: ~₹10,000 crore ($1.0 billion)
  • H2FY27: ~₹20,000 crore ($2.1 billion)
  • FY28: ₹40,000-50,000 crore ($4.2-5.2 billion)
  • FY29-30: ₹50,000-92,000 crore per year ($5.2-9.6 billion)

Product Expansion Roadmap:

  • H2FY27: Digital Personal Loans, Rural Home Loans, Micro LAP Loans
  • FY28: Gold Loans, 2W & 3W Financing, Retail & E-Commerce Lending
  • FY29-30: Rural Loans (Consumer Durable Loans, Digital & Lifestyle Financing, Personal Loan-Salaried, Loan to Professionals, Micro Finance)

Branch Expansion:

  • FY26: 217 branches
  • FY27: 270 branches
  • FY28: ~800 branches (~400 regular, ~400 gold loan)
  • FY29: ~1,300 branches (~500 regular, ~800 gold loan)
  • FY30: ~1,605 branches (~605 regular, ~1,000 gold loan)

Manpower Growth:

  • Current: ~6,000 employees
  • FY27: ~8,000 employees with senior recruitments for new business growth, complexity management, and data-science expertise
  • FY28: ~10,000-12,500 employees
  • FY29-30: ~16,500-20,000 employees

Credit Rating Upgrades:

  • Domestic: AA to AA+ (H1FY27), AA+ to AAA (H2FY27)
  • International: B+ to BB (H1FY27), BB to BB- (H2FY27), BB+ to BBB (FY28)

Cost of Funds Reduction:

  • Incremental CoF: 10.5% to 9.0% (H1FY27), ~9.0% to 8.5% (H2FY27), 8.5% to 7.8% (FY28), 7.8% to 7.2% (FY29-30)
  • Stock CoF: ~10.5% to ~9.6% (H1FY27), ~9.6% to ~9.3% (H2FY27), 9.3% to 8.9% (FY28), 8.9% to 7.8% (FY29-30)

Governance Enhancements:

  • 2 IHC Board members with representative presence on key Board committees
  • Defined AI governance framework with Board & Risk oversight
  • Process of onboarding Big-5 firm as Statutory auditor
  • Onboarding Big-5 firm as Internal Audit co-sourcing partner
  • New Independent Directors to be appointed to strengthen Board
  • Big-5 firm to become Statutory auditor from September 2027

Distinguished Board of Directors

  • Mr. Subhash Sheoratan Mundra (Chairman & Independent Director) - Former Deputy Governor of RBI, completes term on August 17, 2026
  • Mr. Alwyn Crasta (Non-Executive & Non-Independent Director) - Group CFO at IHC (PJSC)
  • H.E. Dalia Khorshid (CEO at Avalora Holding) - CEO & MD at Beltone Holding
  • Mr. Rajiv Gupta (Nominee Director of LIC of India) - Ex-Director & Chairman of LICHFL AMC Ltd
  • Mr. Dinabandhu Mohapatra (Independent Director) - Former MD & CEO of Bank of India, Interim Chairman from August 18, 2026
  • Mr. Achuthan Siddharth (Independent Director) - Former Partner at Deloitte, Haskins & Sells
  • Mrs. Shefali Shah (Independent Director) - Retired Indian Revenue Services Officer
  • Mr. Gagan Banga (MD & CEO)
  • Mr. Sachin Chaudhary (Executive Director & COO)

Shareholding Pattern

  • Avenir (IHC) current stake: 28.5%
  • Expected to increase to ~43.5% upon ~₹3,198 crore warrant infusion
  • Warrant conversion deadline: September 30, 2027